These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 31228941)

  • 1. miR-96-5p promotes the proliferation and migration of ovarian cancer cells by suppressing Caveolae1.
    Liu B; Zhang J; Yang D
    J Ovarian Res; 2019 Jun; 12(1):57. PubMed ID: 31228941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of Long Noncoding RNA H19 Downregulates miR-140-5p and Activates PI3K/AKT Signaling Pathway to Promote Invasion, Migration and Epithelial-Mesenchymal Transition of Ovarian Cancer Cells.
    Xu H; Ding Y; Yang X
    Biomed Res Int; 2021; 2021():6619730. PubMed ID: 34250088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The lncRNA SNHG15/miR-18a-5p axis promotes cell proliferation in ovarian cancer through activating Akt/mTOR signaling pathway.
    Zhang J; Wang L; Jiang J; Qiao Z
    J Cell Biochem; 2020 Dec; 121(12):4699-4710. PubMed ID: 33135285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-139-5p Inhibits Cell Proliferation and Invasion by Targeting RHO-Associated Coiled-Coil-Containing Protein Kinase 2 in Ovarian Cancer.
    Wang Y; Li J; Xu C; Zhang X
    Oncol Res; 2018 Apr; 26(3):411-420. PubMed ID: 28653604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FoxP3-miR-150-5p/3p suppresses ovarian tumorigenesis via an IGF1R/IRS1 pathway feedback loop.
    Zhang Q; Zhou X; Wan M; Zeng X; Luo J; Xu Y; Ji L; Zhang JA; Fan P; Zhong J; Wu J
    Cell Death Dis; 2021 Mar; 12(3):275. PubMed ID: 33723215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CircUBE2D2 regulates HMGB1 through miR-885-5p to promote ovarian cancer malignancy.
    Yan R; Zeng S; Gao F; Li L; Xiao X
    Clinics (Sao Paulo); 2024; 79():100391. PubMed ID: 38848634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylation-mediated repression of MiR-424/503 cluster promotes proliferation and migration of ovarian cancer cells through targeting the hub gene KIF23.
    Li T; Li Y; Gan Y; Tian R; Wu Q; Shu G; Yin G
    Cell Cycle; 2019 Jul; 18(14):1601-1618. PubMed ID: 31135262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TTK (threonine tyrosine kinase) regulates the malignant behaviors of cancer cells and is regulated by microRNA-582-5p in ovarian cancer.
    Lu N; Ren L
    Bioengineered; 2021 Dec; 12(1):5759-5768. PubMed ID: 34516342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosomal miR-940 maintains SRC-mediated oncogenic activity in cancer cells: a possible role for exosomal disposal of tumor suppressor miRNAs.
    Rashed MH; Kanlikilicer P; Rodriguez-Aguayo C; Pichler M; Bayraktar R; Bayraktar E; Ivan C; Filant J; Silva A; Aslan B; Denizli M; Mitra R; Ozpolat B; Calin GA; Sood AK; Abd-Ellah MF; Helal GK; Berestein GL
    Oncotarget; 2017 Mar; 8(12):20145-20164. PubMed ID: 28423620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma exosomal
    Chen L; Wang K; Li L; Zheng B; Zhang Q; Zhang F; Chen J; Wang S
    Future Oncol; 2022 Aug; 18(26):2919-2931. PubMed ID: 35893704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. m6A-modified circASXL1 promotes proliferation and migration of ovarian cancer through the miR-320d/RACGAP1 axis.
    Tian Q; Mu Q; Liu S; Huang K; Tang Y; Zhang P; Zhao J; Shu C
    Carcinogenesis; 2023 Dec; 44(12):859-870. PubMed ID: 37738681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-510 mediated negative regulation of Caveolin-1 in fibroblasts promotes aggressive tumor growth.
    King B; Krisanits BA; Guo QJ; Blake B; Nogueira LM; Jolly G; Satterwhite A; Turner DP; Hoffman S; Evans-Knowell A; Findlay VJ
    Front Immunol; 2023; 14():1116644. PubMed ID: 37822942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined inhibition of HER2 and VEGFR synergistically improves therapeutic efficacy via PI3K-AKT pathway in advanced ovarian cancer.
    Li W; Zhang K; Wang W; Liu Y; Huang J; Zheng M; Li L; Zhang X; Xu M; Chen G; Wang L; Zhang S
    J Exp Clin Cancer Res; 2024 Feb; 43(1):56. PubMed ID: 38403634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-26b regulates cell proliferation and apoptosis of CD117+CD44+ ovarian cancer stem cells by targeting PTEN.
    Gao Z; Ye X; Bordeaux A; Hettich S; Lin S; Han F; Jia Y
    Eur J Histochem; 2021 Feb; 65(1):. PubMed ID: 33634678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of miR-614 promotes proliferation and inhibits apoptosis in ovarian cancer by suppressing PPP2R2A expression.
    Zhang J; Gao D; Zhang H
    Mol Med Rep; 2018 May; 17(5):6285-6292. PubMed ID: 29532877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knockdown of LIMD2 inhibits the progression of ovarian carcinoma through ERK1/2 pathway.
    Hu H; Wang Y; Dong Y; Wang L; Chen Y; Zhou Y; Sun L
    Mol Biol Rep; 2023 Nov; 50(11):8985-8993. PubMed ID: 37716918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroR-9c-5p and novel-mir50 co-target Akt to regulate Lasioderma serricorne reproduction.
    Yan Y; Qin DD; Yang H; Xu KK; Li C; Yang WJ
    Insect Sci; 2024 Feb; 31(1):106-118. PubMed ID: 37350038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive Analyses and Experiments Confirmed IGFBP5 as a Prognostic Predictor Based on an Aging-genomic Landscape Analysis of Ovarian Cancer.
    Fan TY; Xu LL; Zhang HF; Peng J; Liu D; Zou WD; Feng WJ; Qin M; Zhang J; Li H; Li YK
    Curr Cancer Drug Targets; 2024; 24(7):760-778. PubMed ID: 38018207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-344-5p Modulates Cholesterol-Induced β-Cell Apoptosis and Dysfunction Through Regulating Caveolin-1 Expression.
    Sun X; Ji G; Li P; Li W; Li J; Zhu L
    Front Endocrinol (Lausanne); 2021; 12():695164. PubMed ID: 34394002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TOP2A modulates signaling via the AKT/mTOR pathway to promote ovarian cancer cell proliferation.
    Zhang K; Zheng X; Sun Y; Feng X; Wu X; Liu W; Gao C; Yan Y; Tian W; Wang Y
    Cancer Biol Ther; 2024 Dec; 25(1):2325126. PubMed ID: 38445610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.